{"id":"W2793950156","doi":"10.1136/rmdopen-2017-000582","title":"4-year results from the RAPID-PsA phase 3 randomised placebo-controlled trial of certolizumab pegol in psoriatic arthritis","year":2018,"lang":"en","type":"article","venue":"RMD Open","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"ca_institutions":"Memorial University of Newfoundland; Toronto Western Hospital","funders":"UCB Pharma","keywords":"Certolizumab pegol; Medicine; Psoriatic arthritis; Placebo; Internal medicine; Arthritis; Oncology; Rheumatoid arthritis; Alternative medicine; Adalimumab; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004382328,0.001500423,0.002976112,0.0003800653,0.000416845,0.001117115,0.0007180722,0.001900487,0.009141427],"category_scores_gemma":[0.003243948,0.0005420884,0.002486099,0.0003702092,0.0007308578,0.0009271751,0.0004730215,0.002405267,0.0009662386],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004907535,"about_ca_system_score_gemma":0.000759406,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003845557,"about_ca_topic_score_gemma":0.000993975,"domain_scores_codex":[0.9983591,0.0009726995,0.0001321269,0.0001697239,0.000184275,0.0001820448],"domain_scores_gemma":[0.9976603,0.0007187013,0.0008422788,0.0001747368,0.0001804566,0.0004236456],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.981698,0.002284603,0.0008868512,0.0007271808,0.00153806,0.00004689342,0.00002816691,0.0002956526,0.00195205,0.00005063135,0.0009212481,0.009570615],"study_design_scores_gemma":[0.9283651,0.05991624,0.008119955,0.00006772839,0.001647493,0.00007869881,0.00001869223,0.0002546264,0.0004514884,0.0001456895,0.0009126594,0.00002153162],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9682205,0.01905093,0.0009895187,0.0008706478,0.0005315723,0.00296175,0.004073385,0.0001949494,0.003106684],"genre_scores_gemma":[0.9836467,0.00379855,0.001385318,0.00126909,0.0004634979,0.002313478,0.003625578,0.00003531068,0.003462398],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009141427,"threshold_uncertainty_score":0.03058106,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02728568028452725,"score_gpt":0.3212008936669828,"score_spread":0.2939152133824556,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}